AJP - Lung AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 296: L430-L441, 2009. First published January 9, 2009; doi:10.1152/ajplung.90458.2008
1040-0605/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/L430    most recent
90458.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moulakakis, C.
Right arrow Articles by Stamme, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moulakakis, C.
Right arrow Articles by Stamme, C.

Role of clathrin-mediated endocytosis of surfactant protein A by alveolar macrophages in intracellular signaling

Christina Moulakakis1 and Cordula Stamme1,2

1Department of Clinical Medicine, Division of Cellular Pneumology, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel; and 2Department of Anesthesiology, University Hospital of Lübeck, Lübeck, Germany

Submitted 25 August 2008 ; accepted in final form 2 January 2009

We recently provided evidence that anti-inflammatory macrophage activation, i.e., the inhibition of constitutive and signal-induced NF-{kappa}B activity by the pulmonary collectin surfactant protein (SP)-A, critically involves a promoted stabilization of I{kappa}B-{alpha}, the predominant inhibitor of NF-{kappa}B, via posttranscriptional mechanisms comprising the activation of atypical (a)PKC{zeta}. SP-A uptake and degradation by alveolar macrophages (AM{phi}) occur in a receptor-mediated, clathrin-dependent manner. However, a mutual link between endocytosis of and signaling by SP-A remains elusive. The aim of this study was to investigate whether clathrin-mediated endocytosis (CME) of SP-A by AM{phi} is a prerequisite for its modulation of the I{kappa}B-{alpha}/NF-{kappa}B pathway. The inhibition of clathrin-coated pit (CCP) formation and clathrin-coated vesicle (CCV) formation/budding abrogates SP-A-mediated I{kappa}B-{alpha} stabilization and SP-A-mediated inhibition of LPS-induced NF-{kappa}B activation in freshly isolated rat AM{phi}, as determined by Western analysis, fluorescence-activated cell sorting, confocal microscopy, and EMSA. Actin depolymerization and inhibition of CCP formation further abolished SP-A-mediated inhibition of LPS-induced TNF-{alpha} release, as determined by ELISA. In addition, SP-A-induced atypical PKC{zeta} activation was abolished by pretreatment of AM{phi} with CCV inhibitors as determined by in vitro immunocomplex kinase assay. Although CME is classically considered as a means to terminate signaling, our results demonstrate that SP-A uptake via CME by AM{phi} has to precede the initiation of SP-A signaling.

collectins; lung; lipopolysaccharide; nuclear factor-{kappa}B; protein kinase C{zeta}



Address for reprint requests and other correspondence: C. Stamme, Dept. of Clinical Medicine, Division of Cellular Pneumology, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, 23845 Borstel, Germany (e-mail address: cstamme{at}fz-borstel.de)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.